Upper abdominal procedures in advanced stage ovarian or primary peritoneal carcinoma patients with minimal or no gross residual disease: An analysis of Gynecologic Oncology Group (GOG) 182

Gynecologic Oncology

Volumn 130, Issue 3, 2013, Pages 487-492

  Rodriguez, Noah ^a,g   Miller, Austin ^b   Richard, Scott D ^c   Rungruang, Bunja ^c   Hamilton, Chad A ^d   Bookman, Michael A ^e,h   Maxwell, G Larry ^f   Horowitz, Neil S ^a   Krivak, Thomas C ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d WALTER REED ARMY MEDICAL CENTER   (United States)

^e FOX CHASE CANCER CENTER   (United States)

^f INOVA FAIRFAX HOSPITAL   (United States)

^g LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF ARIZONA   (United States)

Author keywords

Ovarian cancer; Surgical debulking; Upper abdominal procedures

Indexed keywords

ABDOMINAL SURGERY; ADULT; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CYTOREDUCTIVE SURGERY; DIAPHRAGM STRIPPING; FEMALE; HUMAN; KAPLAN MEIER METHOD; LIVER RESECTION; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; OVARY CARCINOMA; OVERALL SURVIVAL; PANCREAS RESECTION; PERITONEUM CANCER; PORTA HEPATIS SURGERY; PRIMARY PERITONEAL CANCER; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROPORTIONAL HAZARDS MODEL; SPLENECTOMY;

OVARIAN CANCER; SURGICAL DEBULKING; UPPER ABDOMINAL PROCEDURES;

ABDOMEN; CARCINOMA; DIAPHRAGM; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; MIDDLE AGED; NEOPLASM, RESIDUAL; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PANCREATECTOMY; SPLENECTOMY;

EID: 84882449534     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.06.017     Document Type: Article

References (22)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J Clin 63 2013 11 30
2. C.T. Griffiths Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma Natl Cancer Inst Monogr 42 1975 101 104
3. C.T. Griffiths, and A.F. Fuller Intensive surgical and chemotherapeutic management of advanced ovarian cancer Surg Clin North Am 58 1978 131 142
4. N.F. Hacker, J.S. Berek, L.D. Lagasse, R.K. Nieberg, and R.M. Elashoff Primary cytoreductive surgery for epithelial ovarian cancer Obstet Gynecol 61 1983 413 420
5. G. Delgado, D.H. Oram, and E.S. Petrilli Stage III epithelial ovarian cancer: the role of maximal surgical reduction Gynecol Oncol 18 1984 293 298
6. W.J. Hoskins Epithelial ovarian carcinoma: principles of primary surgery Gynecol Oncol 55 1994 S91 S96
7. D.S. Chi, J.B. Liao, L.F. Leon, E.S. Venkatraman, M.L. Hensley, and D. Bhaskaran Identification of prognostic factors in advanced epithelial ovarian carcinoma Gynecol Oncol 82 2001 532 537
8. W.E. Winter III, G.L. Maxwell, C. Tian, J.W. Carlson, R.F. Ozols, and P.G. Rose Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group study J Clin Oncol 25 2007 3621 3627
9. D.S. Chi, E.L. Eisenhauer, J. Lang, J. Huh, L. Haddad, and N.R. Abu-Rustum What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol 103 2006 559 564
10. R.E. Bristow, R.S. Tomacruz, D.K. Armstrong, E.L. Trimble, and F.J. Montz Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis J Clin Oncol 20 2002 1248 1259
11. W. Kuhn, G. Florack, J. Roder, B. Schmalfeldt, L. Pache, and M. Rust The influence of upper abdominal surgery on perioperative morbidity and mortality in patients with advanced ovarian cancer FIGO III and FIGO IV Int J Gynecol Cancer 8 1998 56 63
12. S.M. Eisenkop, N.M. Spirtos, R.L. Friedman, W.C. Lin, A.L. Pisani, and S. Perticucci Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study Gynecol Oncol 90 2003 390 396
13. G.D. Aletti, S.C. Dowdy, B.S. Gostout, M.B. Jones, C.R. Stanhope, and T.O. Wilson Aggressive surgical effort and improved survival in advanced-stage ovarian cancer Obstet Gynecol 107 2006 77 85
14. D.S. Chi, C.C. Franklin, D.A. Levine, F. Akselrod, P. Sabbatini, and W.R. Jarnagin Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach Gynecol Oncol 94 2004 650 654
15. M.A. Bookman, M.F. Brady, W.P. McGuire, P.G. Harper, D.S. Alberts, and M. Friedlander Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup J Clin Oncol 27 2009 1419 1425
16. D.S. Chi, E.L. Eisenhauer, O. Zivanovic, Y. Sonoda, N.R. Abu-Rustum, and D.A. Levine Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm Gynecol Oncol 114 2009 26 31
17. P.R. Rosenbaum, and D.B. Rubin The central role of the propensity score in observational studies for causal effects Biometrika 70 1983 41 55
18. E.A. Stuart Matching methods for causal inference: a review and a look forward Stat Sci 25 2010 1 21
19. P.M. Magtibay, P.B. Adams, M.B. Silverman, S.S. Cha, and K.C. Podratz Splenectomy as part of cytoreductive surgery in ovarian cancer Gynecol Oncol 102 2006 369 374
20. D.S. Chi, O. Zivanovic, K.L. Levinson, V. Kolev, J. Huh, and J. Dottino The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas Gynecol Oncol 119 2010 38 42
21. S.M. Kehoe, E.L. Eisenhauer, N.R. Abu-Rustum, Y. Sonoda, M. D-Angelica, and W.R. Jarnagin Incidence and management of pancreatic leaks after splenectomy with distal pancreatectomy performed during primary cytoreductive surgery for advanced ovarian, peritoneal and fallopian tube cancer Gynecol Oncol 112 2009 496 500
22. Y. Yildirim, and M. Sanci The feasibility and morbidity of distal pancreatectomy in extensive cytoreductive surgery for advanced epithelial ovarian cancer Arch Gynecol Obstet 272 2005 31 34